{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:51:57Z","timestamp":1768517517978,"version":"3.49.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>Women and health care providers are often fearful of using hormone therapy to deal with distressing menopausal symptoms in circumstances where there is a perceived or real increased risk of breast cancer. This paper examines the evidence for and against hormone therapy use in 3 common clinical situations: the woman with a positive family history in a first-degree relative, the woman who has undergone risk-reducing salpingo-oophorectomy due to a known genetic mutation, and the woman in whom treatment of breast cancer has induced premature menopause.<\/jats:p>","DOI":"10.1097\/grf.0000000000000379","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T23:23:25Z","timestamp":1525994605000},"page":"480-487","source":"Crossref","is-referenced-by-count":2,"title":["Hormone Therapy in Breast Cancer Survivors and Those at High Risk for Breast Cancer"],"prefix":"10.1097","volume":"61","author":[{"given":"ROBERT L.","family":"REID","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ejso.2016.11.011","article-title":"Effects of ovarian ablation or suppression in premenopausal breast cancer: a meta-analysis of randomized controlled trials","volume":"43","author":"Zhang","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/GRF.0000000000000239","article-title":"Breast cancer epidemiology and risk factors","volume":"59","author":"Rojas","year":"2016","journal-title":"Clin Obstet Gynecol"},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10810730701806912","article-title":"A comprehensive analysis of breast cancer news coverage in leading media outlets focusing on environmental risks and prevention","volume":"13","author":"Atkin","year":"2008","journal-title":"J Health Commun"},{"key":"R5-20230911","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001877.pub5","article-title":"Screening for breast cancer with mammography","author":"Gotzsche","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2015.11.016","article-title":"Sexual activity and functioning after risk reducing salpingo-oophorectomy: impact of hormone therapy","volume":"140","author":"Johansen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/13697137.2016.1209396","article-title":"Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation","volume":"19","author":"Guidozzi","year":"2016","journal-title":"Climacteric"},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archinternmed.2012.2329","article-title":"Environmental causes of breast cancer and radiation from medical imaging: findings from the Institute of Medicine report","volume":"172","author":"Smith-Bindman","year":"2012","journal-title":"Arch Intern Med"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-014-2901-2","article-title":"Mammographic density\u2014a review on current understanding of its association with breast cancer","volume":"144","author":"Huo","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B","article-title":"Family history and the risk of breast cancer: a systematic review and meta-analysis","volume":"71","author":"Pharoah","year":"1997","journal-title":"Int J Cancer"},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/CCO.0b013e3283139173","article-title":"Hereditary breast cancer: from bench to bedside","volume":"20","author":"De Greve","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/PRS.0000000000003577","article-title":"Breast cancer genetics for plastic surgeons","volume":"140","author":"McInerney","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"R14-20230911","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AOG.0b013e31825a717b","article-title":"Post-oophorectomy estrogen use and breast cancer risk","volume":"120","author":"Nichols","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1940-6207.CAPR-12-0190","article-title":"Breast cancer incidence after risk reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"5","author":"Fakkert","year":"2012","journal-title":"Cancer Prev Res"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"pii: djv033","DOI":"10.1093\/jnci\/djv033","article-title":"Breast cancer risk after salpingo-oophorectomy in healthy BRCA 1\/2 mutation carriers: revisiting the evidence for risk reduction","volume":"107","author":"Heemskerk-Gerritsen","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J Clin Oncol"},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","article-title":"Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women\u2019s Health Initiative randomized trial of estrogen plus progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"R21-20230911","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/EDE.0b013e3181a71279","article-title":"Hormone replacement therapy, family history and breast cancer risk among postmenopausal women","volume":"20","author":"Gramling","year":"2009","journal-title":"Epidemiology"},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7326\/0003-4819-127-11-199712010-00004","article-title":"The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer","volume":"127","author":"Sellers","year":"1997","journal-title":"Ann Intern Med"},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/aje\/kwu347","article-title":"Hormone therapy and young-onset breast cancer","volume":"181","author":"O\u2019Brien","year":"2015","journal-title":"Am J Epidemiol"},{"key":"R24-20230911","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/M13-1684","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation","volume":"160","author":"Nelson","year":"2014","journal-title":"Ann Intern Med"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","article-title":"Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer","volume":"26","author":"Atchley","year":"2008","journal-title":"J Clin Oncol"},{"key":"R26-20230911","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","article-title":"Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers","volume":"100","author":"Eisen","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R28-20230911","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/GME.0000000000000724","article-title":"Use of systemic hormone therapy in BRCA mutation carriers","volume":"23","author":"Domchek","year":"2016","journal-title":"Menopause"},{"key":"R29-20230911","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/GME.0000000000000126","article-title":"Hormone therapy in oophorectomized BRCA1\/2 mutation carriers","volume":"21","author":"Marchetti","year":"2013","journal-title":"Menopause"},{"key":"R30-20230911","first-page":"1","article-title":"Is hormone replacement therapy safe in women with a BRCA mutation? A systematic review of the contemporary literature","volume":"2","author":"Birrer","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"R31-20230911","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2004.06.090","article-title":"Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1\/2 mutations: a decision analysis","volume":"22","author":"Armstrong","year":"2004","journal-title":"J Clin Oncol"},{"key":"R32-20230911","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ejca.2011.04.007","article-title":"Hormone replacement therapy and women with premature menopause\u2014a cancer survivorship issue","volume":"47","author":"King","year":"2011","journal-title":"Eur J Cancer"},{"key":"R33-20230911","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/13697131003660593","article-title":"Health-related quality of life during hormone therapy after breast cancer: a randomized trial","volume":"14","author":"Fahlen","year":"2011","journal-title":"Climacteric"},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"R535","DOI":"10.1186\/bcr1035","article-title":"Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence","volume":"7","author":"Col","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R35-20230911","first-page":"532","article-title":"Hormone replacement therapy\u2019s effects on recurrence and mortality among breast cancer survivors","volume":"22","author":"Kim","year":"2002","journal-title":"Med Decis Making"},{"key":"R36-20230911","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/humrep\/del393","article-title":"Safety of hormone therapy after breast cancer: a qualitative systematic review","volume":"22","author":"Antoine","year":"2007","journal-title":"Hum Reprod"},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"Holmberg","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R38-20230911","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"Menopausal hormone therapy after breast cancer: the Stockholm randomized trial","volume":"97","author":"von Schoultz","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamaoncol.2016.3904","article-title":"Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial","volume":"3","author":"Melisko","year":"2017","journal-title":"JAMA Oncol"},{"key":"R40-20230911","first-page":"191","article-title":"Systematic review: treatment of atrophic vaginitis in breast cancer patients treated with aromatase inhibitors","volume":"81","author":"Joris","year":"2015","journal-title":"Maturitas"},{"key":"R41-20230911","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1210\/jc.2017-01138","article-title":"Managing menopausal symptoms and associated clinical issues in breast cancer survivors","volume":"102","author":"Santen","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201809000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:15:07Z","timestamp":1694420107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201809000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000379","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}